These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4380482)

  • 1. The pharmacology of actomol and related compounds.
    Spinks A; Whittle BA
    Int J Neuropharmacol; 1966 Jan; 5(1):125-39. PubMed ID: 4380482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative studies on monoamine oxidase inhibitors].
    Matthies H; Lietz W; Fähse C; Pohle W; Popov N; Grade K
    Acta Biol Med Ger; 1966; 17(5):614-36. PubMed ID: 5991587
    [No Abstract]   [Full Text] [Related]  

  • 4. Modaline and locomotor activity in the mouse.
    Gylys JA; Muccia PM
    Arch Int Pharmacodyn Ther; 1967 Apr; 166(2):449-65. PubMed ID: 4382254
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopa-induced excitement in the cat. Its relationship to brain norepinephrine concentrations.
    Reis DJ; Moorhead DT; Merlino N
    Arch Neurol; 1970 Jan; 22(1):31-9. PubMed ID: 4391435
    [No Abstract]   [Full Text] [Related]  

  • 6. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase.
    Andree TH; Clarke DE
    Biochem Pharmacol; 1982 Mar; 31(5):825-30. PubMed ID: 7082351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of monoamine oxidase inhibitors.
    Fujita T
    J Med Chem; 1973 Aug; 16(8):923-30. PubMed ID: 4745836
    [No Abstract]   [Full Text] [Related]  

  • 9. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

  • 10. Direct evidence for a centrally-mediated hypotensive action of L-dopa in anesthetized dogs.
    Kaplan HR; Barker JW; La Sala SA
    Eur J Pharmacol; 1972 Feb; 17(2):273-8. PubMed ID: 4402097
    [No Abstract]   [Full Text] [Related]  

  • 11. The analgesic activity of phenelzine and other compounds.
    EMELE JF; SHANAMAN J; WARREN MR
    J Pharmacol Exp Ther; 1961 Nov; 134():206-9. PubMed ID: 13890095
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of acylation with eleostearic acids on the monoamine oxidase inhibitory potency of some hydrazine antidepressants in mice.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1975 Jan; 18(1):20-3. PubMed ID: 1109570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1971 Mar; 6(3):215-7. PubMed ID: 5125476
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of homoveratrylamine on the operant behavior of rats. Potentiation by phenelzine.
    Bueno OF; Masur J; Breda JB; Carlini EA
    Acta Physiol Lat Am; 1969; 19(3):181-7. PubMed ID: 5374271
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of effects of L-dopa on conditioned avoidance behavior by inhibition of extracerebral dopa decarboxylase.
    Seiden LS; Martin TW
    Physiol Behav; 1971 Apr; 6(4):453-8. PubMed ID: 5148757
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological studies on modaline sulphate (w 3207).
    Jori A; Carrara C; Paglialunga S; Garattini S
    J Pharm Pharmacol; 1965 Nov; 17(11):703-9. PubMed ID: 4379803
    [No Abstract]   [Full Text] [Related]  

  • 17. [ON THE NEUROTROPIC EFFECT OF 3,4-DIMETHOXYBENZYLHYDRAZINE (VETRAZINE)].
    KUDRIN AN; KOROZA GS; ORLOV IV; RIABOKON NA
    Farmakol Toksikol; 1964; 27():160-5. PubMed ID: 14193077
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible role of hydrazine group in hypoglycemia associated with the use of certain monoamine-oxidase inhibitors (MAOI's).
    Potter WZ; Zaharko DS; Beck LV
    Diabetes; 1969 Aug; 18(8):538-41. PubMed ID: 5808748
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the potentiation of DOPA effects by monoamine oxidase inhibitors].
    Boissier JR; Simon P
    Psychopharmacologia; 1966; 8(6):428-36. PubMed ID: 5923750
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.